Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Duhachek Muggy

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
BMC Cancer|April 18, 2015
ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancerSara Duhachek-Muggy, Anna Zolkiewska
Breast Cancer Research and Treatment|June 18, 2013
Metalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotypeHui Li, Sara Duhachek-Muggy, Suzanne Dubnicka, et al.
Plos One|October 12, 2013
Alternative mRNA splicing generates two distinct ADAM12 prodomain variantsSara Duhachek-Muggy, Hui Li, Yue Qi, et al.
Radiation Research|August 23, 2017
Growth Differentiation Factor 11 does not Mitigate the Lethal Effects of Total-Abdominal IrradiationSara Duhachek-Muggy, Kruttika Bhat, Erina Vlashi, et al.
Plos One|March 22, 2014
Phenotypic diversity of breast cancer-related mutations in metalloproteinase-disintegrin ADAM12Yue Qi, Sara Duhachek-Muggy, Hui Li, et al.
Rand Health Quarterly|December 12, 2024
Modern Biosurveillance Methods: A Lay Introduction to Effective Use of Nucleic Acid MethodsSara Duhachek Muggy, Mary Avriette, Derek Roberts, et al.
Breast Cancer Research and Treatment|May 11, 2016
Protein disulfide isomerases in the endoplasmic reticulum promote anchorage-independent growth of breast cancer cellsRandi Wise, Sara Duhachek-Muggy, Yue Qi, et al.
The Journal of Biological Chemistry|May 12, 2010
The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12Emilia Solomon, Hui Li, Sara Duhachek Muggy, et al.
The Journal of Biological Chemistry|April 27, 2011
Metalloprotease-disintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29Hui Li, Emilia Solomon, Sara Duhachek Muggy, et al.
Breast Cancer Research and Treatment|August 29, 2012
An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancerHui Li, Sara Duhachek-Muggy, Yue Qi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
BMC Cancer|April 18, 2015
ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancerSara Duhachek-Muggy, Anna Zolkiewska
Breast Cancer Research and Treatment|June 18, 2013
Metalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotypeHui Li, Sara Duhachek-Muggy, Suzanne Dubnicka, et al.
Plos One|October 12, 2013
Alternative mRNA splicing generates two distinct ADAM12 prodomain variantsSara Duhachek-Muggy, Hui Li, Yue Qi, et al.
Radiation Research|August 23, 2017
Growth Differentiation Factor 11 does not Mitigate the Lethal Effects of Total-Abdominal IrradiationSara Duhachek-Muggy, Kruttika Bhat, Erina Vlashi, et al.
Plos One|March 22, 2014
Phenotypic diversity of breast cancer-related mutations in metalloproteinase-disintegrin ADAM12Yue Qi, Sara Duhachek-Muggy, Hui Li, et al.
Rand Health Quarterly|December 12, 2024
Modern Biosurveillance Methods: A Lay Introduction to Effective Use of Nucleic Acid MethodsSara Duhachek Muggy, Mary Avriette, Derek Roberts, et al.
Breast Cancer Research and Treatment|May 11, 2016
Protein disulfide isomerases in the endoplasmic reticulum promote anchorage-independent growth of breast cancer cellsRandi Wise, Sara Duhachek-Muggy, Yue Qi, et al.
The Journal of Biological Chemistry|May 12, 2010
The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12Emilia Solomon, Hui Li, Sara Duhachek Muggy, et al.
The Journal of Biological Chemistry|April 27, 2011
Metalloprotease-disintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29Hui Li, Emilia Solomon, Sara Duhachek Muggy, et al.
Breast Cancer Research and Treatment|August 29, 2012
An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancerHui Li, Sara Duhachek-Muggy, Yue Qi, et al.
Pageof 2